Peter Thiel-backed psychedelic startup targets schizophrenia ahead of IPO – CNBC
Peter Thiel-backed psychedelic startup targets schizophrenia ahead of IPO – CNBC
LONDON – ATAI Life Science, a start-up backed by Peter Thiel, has taken a majority stake in Recognify, a company that develops drugs to help treat schizophrenia. Based in Berlin, ATAI aims to manufacture psychedelic drugs that can be used to treat mental health disorders. Recognize, meanwhile, is specifically aimed at making a drug that […]
The post Peter Thiel-backed psychedelic startup targets…
Discover more from USNewsRank
Subscribe to get the latest posts sent to your email.